Carl Zeiss Meditec (0DHC) Income Statement
Carl Zeiss Meditec Income Statement
Last quarter (Q3 2026), Carl Zeiss Meditec's total revenue was $562.72M, an increase of 2.38% from the same quarter last year. In Q3, Carl Zeiss Meditec's net income was $55.03M. See Carl Zeiss Meditec’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| $ 2.23B | $ 2.07B | $ 2.09B | $ 1.90B | $ 1.65B | |
| $ 1.18B | $ 1.09B | $ 1.21B | $ 1.13B | $ 967.21M | |
| $ 951.88M | $ 894.18M | $ 857.64M | $ 730.72M | $ 593.60M | |
| Depreciation and Amortization | $ 126.38M | $ 132.77M | $ 74.06M | $ 69.77M | $ 61.58M |
| $ 346.89M | $ 403.06M | $ 501.88M | $ 482.85M | $ 410.00M | |
| $ 223.32M | $ 194.45M | $ 348.12M | $ 396.88M | $ 373.61M | |
| $ -29.43M | $ 46.41M | $ 64.44M | $ 6.61M | $ -34.56M | |
| $ 193.89M | $ 240.87M | $ 412.56M | $ 403.49M | $ 339.05M | |
| $ 141.21M | $ 178.73M | $ 290.40M | $ 293.91M | $ 236.28M | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.61 | $ 2.01 | $ 3.25 | $ 3.29 | $ 2.64 |
| Diluted EPS | $ 1.61 | $ 2.01 | $ 3.25 | $ 3.29 | $ 2.64 |
| Weighted Average Shares Outstanding | 87.54M | 88.85M | 89.44M | 89.44M | 89.44M |
| Weighted Average Shares Outstanding (Diluted) | 87.54M | 88.85M | 89.44M | 89.44M | 89.44M |
Currency in EUR